A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer
Active, not recruiting · NCT05160545 · Registry updated 2025-09-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 1 | 2025-09-26 | NCT05160545 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. | 110 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 135 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dongguan People's Hospital | Dongguan | China | 23 |
| Sun Yat-sen Memorial Hospital, Sun Yat-sen University | Guangzhou | China | 67 |
| The First Affiliated Hospital of Bengbu Medical College | Bengbu | China | 15 |
| The Third Hospital of Changsha | Changsha | China | 3 |
| West China Hospital，Sichuan University | Chengdu | China | 12 |
| ZhuJiang Hospital of Southern Medical University | Guangzhou | China | 27 |